Crossmark Global Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,603
| Closed | -$211K | – | 1375 |
|
|
2025
Q1 | $211K | Buy |
+1,603
| New | +$211K | ﹤0.01% | 1245 |
|
|
2024
Q3 | – | Sell |
-4,652
| Closed | -$319K | – | 1363 |
|
|
2024
Q2 | $319K | Sell |
4,652
-1,520
| -25% | -$104K | 0.01% | 1041 |
|
|
2024
Q1 | $427K | Sell |
6,172
-2,027
| -25% | -$140K | 0.01% | 938 |
|
|
2023
Q4 | $587K | Hold |
8,199
| – | – | 0.01% | 779 |
|
|
2023
Q3 | $445K | Buy |
8,199
+533
| +7% | +$28.9K | 0.01% | 867 |
|
|
2023
Q2 | $466K | Buy |
7,666
+10
| +0.1% | +$608 | 0.01% | 887 |
|
|
2023
Q1 | $415K | Sell |
7,656
-6
| -0.1% | -$325 | 0.01% | 907 |
|
|
2022
Q4 | $405K | Buy |
7,662
+685
| +10% | +$36.2K | 0.01% | 880 |
|
|
2022
Q3 | $325K | Buy |
6,977
+1,027
| +17% | +$47.8K | 0.01% | 955 |
|
|
2022
Q2 | $340K | Buy |
+5,950
| New | +$340K | 0.01% | 978 |
|